GlassScriptPhysician profile
Mark R Meese
NPI 1407817802
$1,035.00
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $263 · 2021: $215 · 2022: $197 · 2023: $128 · 2024: $25.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $221.37 | 2019-2022 | |
| Stryker Corporation | $97.81 | 2023 | Spy-Phi System |
| Davol INC. | $70.15 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $65.41 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.48 | 2020-2024 | Gattex |
| Endo Pharmaceuticals INC. | $52.14 | 2020-2022 | |
| Conmed Corporation | $48.25 | 2022 | |
| Biom'Up France Sas | $47.93 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $47.62 | 2019-2021 | |
| Shire North American Group INC | $34.44 | 2019 | |
| Tei Biosciences INC | $31.07 | 2019 | |
| Kci USA, INC. | $29.67 | 2019-2020 | |
| Teleflex LLC | $27.22 | 2021-2023 | Titan Sgs Standard Gastric Stapler |
| Abbott Laboratories | $26.87 | 2022 | |
| Nestle Healthcare Nutrition INC. | $23.43 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trevena, INC. | $22.74 | 2021 | |
| Apollo Endosurgery US INC | $18.51 | 2019 | |
| Angiodynamics, INC. | $16.31 | 2023 | Smart Port Ct |
| Kowa Pharmaceuticals America, INC. | $16.29 | 2022 | |
| W. L. Gore & Associates, INC. | $14.62 | 2020 | |
| Smith+Nephew, INC. | $12.40 | 2022 | |
| Baudax Bio INC. | $12.24 | 2021 | |
| Tela Bio, INC. | $12.03 | 2020 | |
| Medtronic, INC. | $11.56 | 2021 | |
| Acell, INC. | $10.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Meese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.